BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19326418)

  • 1. Male gonadal toxicity.
    Meistrich ML
    Pediatr Blood Cancer; 2009 Aug; 53(2):261-6. PubMed ID: 19326418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chemotherapy and radiotherapy on spermatogenesis in humans.
    Meistrich ML
    Fertil Steril; 2013 Nov; 100(5):1180-6. PubMed ID: 24012199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal damage from chemotherapy and radiotherapy.
    Howell S; Shalet S
    Endocrinol Metab Clin North Am; 1998 Dec; 27(4):927-43. PubMed ID: 9922915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cancer therapy on pituitary-testicular axis.
    Howell SJ; Shalet SM
    Int J Androl; 2002 Oct; 25(5):269-76. PubMed ID: 12270023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male gonadal function after chemotherapy for solid tumors in childhood.
    Aubier F; Flamant F; Brauner R; Caillaud JM; Chaussain JM; Lemerle J
    J Clin Oncol; 1989 Mar; 7(3):304-9. PubMed ID: 2493074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
    Sieniawski M; Reineke T; Josting A; Nogova L; Behringer K; Halbsguth T; Fuchs M; Diehl V; Engert A
    Ann Oncol; 2008 Oct; 19(10):1795-801. PubMed ID: 18544558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility preservation options for prepubertal boys facing gonadotoxic therapies.
    Hussein AA; Yango P; Ezz Y; Smith JF; Tran ND
    Minerva Ginecol; 2016 Dec; 68(6):668-74. PubMed ID: 27619261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
    Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
    Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
    Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
    Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
    Blumenfeld Z
    Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk of azoospermia in men treated for childhood cancer.
    Romerius P; Ståhl O; Moëll C; Relander T; Cavallin-Ståhl E; Wiebe T; Giwercman YL; Giwercman A
    Int J Androl; 2011 Feb; 34(1):69-76. PubMed ID: 20345878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of gonadal function from cytotoxic chemotherapy and irradiation.
    Morris ID; Shalet SM
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):97-118. PubMed ID: 2202291
    [No Abstract]   [Full Text] [Related]  

  • 14. Gonadal function of young adults after therapy of malignancies during childhood or adolescence.
    Müller HL; Klinkhammer-Schalke M; Seelbach-Göbel B; Hartmann AA; Kühl J
    Eur J Pediatr; 1996 Sep; 155(9):763-9. PubMed ID: 8874108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbance of pubertal development after cancer treatment.
    Müller J
    Best Pract Res Clin Endocrinol Metab; 2002 Mar; 16(1):91-103. PubMed ID: 11987901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia following chemotherapy for ovarian cancer.
    Kaldor JM; Day NE; Pettersson F; Clarke EA; Pedersen D; Mehnert W; Bell J; Høst H; Prior P; Karjalainen S
    N Engl J Med; 1990 Jan; 322(1):1-6. PubMed ID: 2104664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermatogenesis after cancer treatment: damage and recovery.
    Howell SJ; Shalet SM
    J Natl Cancer Inst Monogr; 2005; (34):12-7. PubMed ID: 15784814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.
    Lee JL; Gooley T; Bensinger W; Schiffman K; McDonald GB
    Biol Blood Marrow Transplant; 1999; 5(5):306-15. PubMed ID: 10534061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gonadal function in young men after the treatment for Hodgkin lymphoma].
    Krawczuk-Rybak M; Solarz E; Wojtkowska M; Wysocka J; Matysiak M; Gadomski A; Kazanowska B; Sega-Pondel D
    Pediatr Endocrinol Diabetes Metab; 2009; 15(2):85-92. PubMed ID: 19772815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of radiation therapy and chemotherapy on testicular function.
    Kinsella TJ
    Prog Clin Biol Res; 1989; 302():157-71; discussion 172-7. PubMed ID: 2666987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.